As of 2024-07-27, the Relative Valuation of Tonix Pharmaceuticals Holding Corp (TNXP) is (164.57) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.55 USD, the upside of Tonix Pharmaceuticals Holding Corp based on Relative Valuation is -30021.9%.
The range of the Relative Valuation is (174.04) - (170.08) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 30.8x - 31.8x | 31.3x |
| Forward P/E multiples | 23.8x - 30.1x | 27.0x |
| Fair Price | (174.04) - (170.08) | (164.57) |
| Upside | -31742.7% - -31023.6% | -30021.9% |
| Date | P/E |
| 2024-07-26 | -0.10 |
| 2024-07-25 | -0.10 |
| 2024-07-24 | -0.09 |
| 2024-07-23 | -0.10 |
| 2024-07-22 | -0.10 |
| 2024-07-19 | -0.10 |
| 2024-07-18 | -0.10 |
| 2024-07-17 | -0.11 |
| 2024-07-16 | -0.11 |
| 2024-07-15 | -0.11 |
| 2024-07-12 | -0.11 |
| 2024-07-11 | -0.11 |
| 2024-07-10 | -0.11 |
| 2024-07-09 | -0.11 |
| 2024-07-08 | -0.13 |
| 2024-07-05 | -0.14 |
| 2024-07-03 | -0.16 |
| 2024-07-02 | -0.13 |
| 2024-07-01 | -0.13 |
| 2024-06-28 | -0.12 |
| 2024-06-27 | -0.12 |
| 2024-06-26 | -0.20 |
| 2024-06-25 | -0.22 |
| 2024-06-24 | -0.21 |
| 2024-06-21 | -0.23 |
| 2024-06-20 | -0.24 |
| 2024-06-18 | -0.22 |
| 2024-06-17 | -0.20 |
| 2024-06-14 | -0.20 |
| 2024-06-13 | -0.19 |
| 2024-06-12 | -0.20 |
| 2024-06-11 | -0.38 |
| 2024-06-10 | -0.39 |
| 2024-06-07 | -0.59 |
| 2024-06-06 | -0.62 |
| 2024-06-05 | -0.86 |
| 2024-06-04 | -0.88 |
| 2024-06-03 | -0.92 |
| 2024-05-31 | -0.92 |
| 2024-05-30 | -0.96 |
| 2024-05-29 | -0.97 |
| 2024-05-28 | -0.96 |
| 2024-05-24 | -0.99 |
| 2024-05-23 | -0.99 |
| 2024-05-22 | -1.08 |
| 2024-05-21 | -1.04 |
| 2024-05-20 | -1.08 |
| 2024-05-17 | -1.12 |
| 2024-05-16 | -1.03 |
| 2024-05-15 | -1.03 |